Priority Medicines for the Citizens of Europe and the World

  The Hague , Thursday 18 November 2004                  

Venue :                       Nieuwe Kerk (‘New Church’, AD 1656), The Hague

Conference chair:     Mr Hans Hoogervorst, Minister of Health, Welfare and Sport,

assisted by:               Mr Hugo Hurts, Director Department of Pharmaceutical Affairs

                                    and Medical Technology

15.00              Reception offered courtesy of The Hague City Council

15.45              Welcome

                        Mr Wim Deetman, Mayor of the City of The Hague , will speak a word of welcome to the guests to his city, which is renowned for its broad international orientation

15.55              Opening

                        Mr Hans Hoogervorst, Minister of Health, Welfare and Sport, The Netherlands

16.05              WHO study ‘Priority Medicines for Europe and the World’

Dr Vladimir Lepakhin, Assistant Director-General, World Health Organization, responsible for medicines and medical technology

and Dr Richard Laing, WHO/EDM, Geneva

The study establishes a solid methodology for priority setting, and identifies a number of pharmacotherapeutic gaps that deserve priority in R&D agendas                

16.20              The Role of the European Investment Bank Group in Priority Medicines: Finance, Incentive Mechanisms and the Project Follow-Up Phase

                        Mr Michel Deleau, Director-General, Projects Directorate, EIB, Luxemburg     

16.35              Preliminary results of the establishment of a European Research Area Network (ERANET) of European Health Research Councils

Mr Dick Dees, chairman of the Board of the Netherlands Organisation for Health Research and Development (‘ZonMw’), former State Secretary for Health of the Netherlands ,

16.50           Keynote address

on behalf of the EC Commissioner for Science and Research:

Dr Octavi Quintana Trias, Director Health Research

Keynote address

on behalf of the Commissioner for Health and Consumer Protection:

Mr Bernard Merkel, Head of Health Strategy at DG Sanco

Keynote address

on behalf of the Commissioner for Enterprise and Industry:

Mr Paul Weissenberg, Director Pharmaceutical Affairs

17.20                           Intermezzo  -  a drink will be served in the conference hall

17.45              Mini-concert by the ‘Muzenkoor’ (Ministry choir)

Mr Hans Matla , conductor  

18.00         Stakeholder debate

Ms Janet Voûte (US), moderator,

CEO of the World Heart Federation ( Geneva ) who will ensure that the patient/consumer will receives adequate attention in the debate

                        Five panel members (in alphabetical order):

                        Ms Karien van Gennip MBA, State Secretary for Economic Affairs, Minister for Foreign Trade, the Netherlands ,

                        Remit: innovation policy       

                        Professor Göran Hermerén ( Sweden ), Chairman of the European Group on Ethics, adviser to the President of the European Commission

Remit: ethics and Priority Medicines, a long-term investment

Professor Herre Kingma, Inspector-General, Dutch Health Inspectorate, providing some of the views of the Chief Medical Officers of the EU member states,

Remit: public health and the health profession

Dr Richard Laing, WHO/EDM, Geneva

Remit: contribution to the discussion by the principal investigator in the WHO study

Mr Andrew Witty, President GlaxoSmithKline Europe

Remit: What can the innovating pharma industry contribute to Priority Medicines?  

19.00              Videoconference link with the Ministerial Summit on

                        Health Research in Mexico City

Mr Hans Hoogervorst, Minister of Health, Welfare and Sport, the Netherlands

                        Remit: Priority Medicines as a basis for further policy making and research in the EU, a common endeavour: summing up and conclusions  

Mr Julio Frenk Mora, Secretary of Health , Mexico

Remit: The relevance of the Priority Medicines Initiative in the global context; comments and suggestions on behalf of the Ministerial Summit on Health Research in Mexico City

19.25                Dr Jong Wook Lee, Director-General of WHO, Geneva , speaking from Mexico City (videotape)

Remit: The relevance of the Priority Medicines Initiative in the global context; comments and suggestions on behalf of the Ministerial Summit on Health Research in Mexico City

Lord Norman Warner, Health Minister , United Kingdom (videotape)

Remit: The forthcoming UK Presidency of the European Union: possible follow-up to the Priority Medicines Project

19.30                           End of conference

20.00 -           RECEPTION AND BUFFET-DINNER AT THE HEALTH MINISTRY

22.00             End of programme